Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 BARDA, JPEO-CBRND and Ology Bioservices join forces to expand fill-finish capacity of COVID-19 vaccines, therapeutics
2 CCDC Chemical Biological Center's Mobile Lab Expertise Enables Readiness
3 FLIR Receives Additional $26M Contract for US Army's Nuclear, Biological and Chemical Reconnaissance Vehicle Program
4 US Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva
5 Vandy discovers long-acting COVID-19 antibodies | Coronavirus News |
6 GRAM partners with Johnson & Johnson on vaccine production
7 Safeguarding Troops from CBRN Threats
8 DoD Expands US Domestic Diagnostics Capacity with $481M Cue Health Deal
9 Trump Administration Expands Collaboration with AstraZeneca to Develop and Manufacture an Investigational Monoclonal Antibody to Prevent COVID-19
10 AFICC increases COVID-19 testing capabilities at 42 medical centers
11 HHS, DoD offer Cytiva $31M to expand manufacturing capacity of COVID-19 vaccine components
12 Cue Secures $481M DoD OTA to Manufacture Coronavirus Diagnostic Tests
13 Alabama company wins big contract for Covid-19 vaccine effort
14 BARDA Balks at "Warp Speed" Funding for Oragenics COVID-19 Vaccine
15 US DoD to lead ramp up of COVID-19 test production
16 MIS-C Detection: BARDA Invests in Rapid Diagnostic for Pediatric Complication of SARS-CoV-2
17 Oragenics (OGEN) announces BARDA determination not to enter into negotiation
18 Cepheid gains federal support for single, rapid diagnostic test for COVID-19, influenza and RSV
19 AstraZeneca receives $486M in U.S. funding to advance Covid-19 antibody treatment
20 New chart reveals military's vast involvement in Operation Warp Speed
21 Trump Administration Expands Collaboration With AstraZeneca (AZN) to Develop and Manufacture an Investigational Monoclonal Antibody to Prevent COVID-19
22 AstraZeneca Inks $486M COVID-19 Antibody Deal With Gov't
23 FDA Places Partial Clinical Hold on INOVIO Trial of COVID-19 Vaccine
24 GRAM Partners with Johnson & Johnson on Manufacturing in Fight Against COVID-19
25 JPEO-CBRND Works with Industry to Develop COVID-19 Diagnostic Tests
26 Takeda's Phase 3 Study Of SC Entyvio Shows Benefits Sustained In Long-term Maintenance Therapy In UC
28 SAB Receives $35.6 Miliion from US DOD
29 INOVIO's COVID-19 Vaccine Trial Put on Partial Clinical Hold by FDA
30 Emergent BioSolutions' COVID-19 Human Immune Globulin Product Candidate to be Included in NIH-Sponsored Phase 3 Clinical Trial of Hyperimmune Intravenous Immunoglobulin to Treat COVID-19
31 News
33 Just
34 CCDC Chemical Biological Center Helps Air Force Design, Test and Field Large-Scale COVID-19 Transport Capability in Record Time
35 Chem-Bio Defense Office Reorganizes to Take on New Threats
36 126th Assembly: Carabajal and Lemondes compete for open Finch seat
38 No “mixed messages”, Russia really has no preference in November
39 Joint Services CBRND Office Realigns To Focus On Protection, Sensors And Medical
40 Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19
41 U.S. Government Issues RFI for Solutions to Combat Coronavirus (COVID-19)
42 Global CBRN Market Analysis & Technologies, 2020-2028
43 Global CBRN Market and Technology Forecast to 2028
44 Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoconal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense
45 BARDA and JPEO-CBRND strike two partnerships to expand domestic manufacturing for needles, syringes
46 Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
47 Coronavirus Pandemic Solutions Sought by Government
48 Militarizing Global Health Isn't the Right Answer
49 News
50 Ology Bioservices Gets $42.6M DoD Contract
51 Watch Public Health Execs speak at Women of Color's all-virtual STEM Conference
52 Novavax Awarded Department of Defense Contract for COVID-19 Vaccine
53 JPEO-CBD Activates New Joint Project Management Office of Medical Countermeasure Systems (MCS)
54 PhysIQ, Department of Defense, and The Henry M. Jackson Foundation for the Advancement of Military Medicine Partner to Deploy Continuous Remote Monitoring Platform to Study COVID-19
55 HHS, DoD provide advanced development support for Cepheid's COVID-1- rapid diagnostic
56 Negatively pressurized conexes ready to save lives
57 Alachua's Ology Bioservices Wins $42.6 Million Department of Defense Contract
58 Trump administration collaborates with Moderna to produce 100M doses of COVID-19 investigational vaccine
59 MRIGlobal To Deliver Three Mobile Medical Labs For Department Of Defense
60 Mount Sinai, Emergent, And ImmunoTek Form Collaboration
61 Ology Bioservices, Inovio (INO) Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
62 Latest sensor upgrades boost recon vehicle capabilities
63 Chem-Bio Defense Program Eases Path for Industry
64 HHS, DoD Ink $1.5B Deal With Moderna for COVID-19 Vaccine Production
65 Army microbiologist deploys to mobile medical lab
66 Chem-Bio Office Cutting Acquisition Red Tape
67 AFLCMC-led team delivers isolation container prototype for testing
68 Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent's COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding
69 Collaboration Made NBCRV's Sensor Suite Upgrade Possible
70 Efforts to counter WMD threats complicated by data challenges
71 Urgent Acquisition Effort Provides Safe COVID-19 Patient Transport in 95 Days
72 Emergent lands $20M contract to develop chemical weapon antidote
73 Ology Bioservices to Adapt Veroplex® Cell Platform for Rapid Response to Viral Threats for Department of Defense
74 Air Force Fields Next Generation CBRN Protective Masks for Rotary Wing Aircrew
75 U.S. Departments of Defense, Health & Human Services select Corning Valor® Glass packaging to accelerate delivery of COVID-19 vaccines
76 Smiths Medical Partners With U.S. Government on COVID-19 Vaccine Efforts
77 SAB wins contract to develop rapid response antibody for US DOD
78 Auburn company scores $143M contract to aid Covid-19 vaccine efforts
79 DTRA engages partners, industry at CWMD conference
80 Bavarian Nordic Announces Topline Results from Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
81 U.S. Army taps FLIR Systems for new chemical agent disclosure spray
82 U.S. Army prepares for nerve agent attacks
83 SAB Biotherapeutics Advances Therapeutic for COVID-19 in Partnership with Department of Defense and BARDA
84 Johns Hopkins researchers get $35M grant to test COVID-19 outpatient treatment
85 Operation Warp Speed turns to DoD to host phase 3 clinical trial of AstraZeneca's COVID-19 vaccine
86 Global Strike Command Opens New Innovation Hub
87 Block Chosen for $8B JPEO-CBD Contract for CBRN (Learn More)
88 Regeneron Announces Manufacturing and Supply Agreement for BARDA and US Department of Defense for REGN-COV2 Anti-Viral Antibody Cocktail
89 SAB and DoD advance therapeutic drug candidate for Covid-19
90 Alion to Support U.S. Chemical, Biological, and Nuclear Defense
91 HHS, DoD Sign $2B Coronavirus Vaccine Deal With Pfizer-BioNTech Partnership
92 Q&A released with JPEO-CBRND, US Army ahead of SMi's Future Armoured Vehicles Survivability 2019
93 Kratos Mobile Laboratory Product Supporting COVID-19 Response Efforts
94 Defense Dept. to Use mHealth Wearables to Test COVID-19 Treatments
95 Army command leading effort to produce 3D-printed test swabs
96 Defense Officials See Increased Threat from Chinese Russian ChemBio Weapon
97 HHS, DoD Award $2.05B in COVID-19 Vaccine, Treatment Production Contracts; Alex Azar Quoted
99 ATI Supports DoD JATF Search For Sources Of Critical Material In Support Of COVID-19 Pandemic Response
100 JUPITR program takes shape on Korean Peninsula